83 / 490
SATURDAY 30 APRIL 2016
81
SCIENTIFIC PROGRAMME
| PROGRAMME AND EXHIBITION GUIDE
17:20 > Management of patients with extensive-stage small-cell lung cancer:
A European survey of practice
K. Haslett (UK), D. De Ruysscher, R. Dziadziuszko,
M. Guckenberger, C. Le Pechoux, U. Nestle, C. Faivre-Finn
OC-0140
Proffered Papers
CLINICAL 4: LATE BREAKING ABSTRACTS
16:30 - 17:30 | GIALLA
Chair: L. Kepka (Poland)
Chair: U. Nestle (Germany)
16:30 > Does an integrated boost increase acute toxicity in prone hypofractiona-
ted breast irradiation?
L. Paelinck, A. Gulyban, F. Lakosi, T. Vercauteren, W. De Gersem,
B. Speleers, C. Monten, T. Mulliez, P. Berkovic, A. Van Greveling,
P. Coucke, W. De Neve, L. Veldeman (Belgium)
OC-0141
16:40 > Hypo- vs normofractionated radiation of early breast cancer in the
randomised DBCG HYPO trial
B.V. Offersen (Denmark), E.H. Jacobsen, M.H. Nielsen, M. Krause,
L. Stenbygaard, I. Mjaaland, A. Schreiber, U.M. Kasti, M.B. Jensen,
J. Overgaard
OC-0142
16:50 > A Bayesian randomisation trial of IMRT vs. PSPT for locally advanced
non-small cell lung carcinoma
Z. Liao (USA), J. Lee, R. Komaki, D. Gomez, M. O’Reilly, P. Allen,
F. Fossella, J. Heymach, N. Choi, T. Delaney, S. Hahn, C. Lu, J. Cox,
R. Mohan
OC-0143
17:00 > Maximum response and PCI are important prognostic factors in LD
SCLC patients staged with cMRI
C. Eze (Germany), O. Roengvoraphoj, M. Niyazi, S. Gerum, G. Hildebrandt,
R. Fietkau, C. Belka, F. Manapov
OC-0144
17:10 > Preoperative radiotherapy with an integrated boost compared to
chemoradiotherapy for rectal cancer
M. De Ridder (Belgium), A. De Paoli, E. Delmastro, F. Munoz, S. Vagge,
D. Norkus, H. Everaert, G. Tabaro, E. Garibaldi, U. Ricardi, E. Borsatti,
T. Gevaert, P. Gabriele, G. Boz, A. Sermeus, M.A. MahéB. Engels
OC-0145